Arcus Biosciences, Inc. · NYSE:RCUS
Arcus Biosciences, Inc. shareholders
As of Jun 30, 2026, 220 institutions reported holding Arcus Biosciences, Inc., 96.3% of its shares. Largest: Gilead Sciences, Inc., BlackRock and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Arcus Biosciences, Inc. | Change | Filed |
|---|---|---|---|---|
| Gilead Sciences, Inc. | 31.4M | 24.7% | no change | Aug 3, 2026 |
| BlackRock | 16.4M | 12.9% | +1.19M | Aug 7, 2026 |
| Vanguard | 9.11M | 7.2% | +273K | Aug 13, 2026 |
| State Street | 6.03M | 4.7% | +617K | Aug 7, 2026 |
| Wellington | 5.9M | 4.6% | −194K | Aug 14, 2026 |
| Montanova Capital, LLC | 4.78M | 3.8% | −255K | Aug 14, 2026 |
| Fidelity | 4.05M | 3.2% | +2.88M | Aug 13, 2026 |
| Citadel | 3.14M | 2.5% | +1.81M | Aug 14, 2026 |
| Woodline Partners LP | 3.01M | 2.4% | −770K | Aug 14, 2026 |
| Geode Capital | 2.45M | 1.9% | +196K | Aug 12, 2026 |